NCT05883150 is a Phase 2, PHASE3 clinical trial of Nebulized Midazolam in Dental Sedation, sponsored by Nourhan M.Aly.

Who is sponsoring NCT05883150?

NCT05883150 is sponsored by Nourhan M.Aly.

What drugs are being tested in NCT05883150?

Interventions in NCT05883150: Nebulized Midazolam, Intranasal Midazolam.

What condition does NCT05883150 study?

NCT05883150 studies Dental Sedation.

Is NCT05883150 still recruiting?

NCT05883150 is currently completed. Last updated 21 November 2023.

Last reviewed 2023-11-21 · How we verify

NCT05883150

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intranasal Versus Nebulized Midazolam in Behaviuor Modification of Preschool Children Undergoing Dental Treatment

Completed Phase 2, PHASE3 Last updated 21 November 2023

What this trial tests

Phase 2, PHASE3 trial testing Nebulized Midazolam in Dental Sedation in 68 participants. Completed in 30 August 2023.

Timeline

10 November 2022

Primary endpoint
30 August 2023

30 August 2023

Quick facts

Lead sponsor	Nourhan M.Aly
Phase	Phase 2, PHASE3
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	68
Start date	10 November 2022
Primary completion	30 August 2023
Estimated completion	30 August 2023
Sites	1 location across Egypt

Drugs / interventions tested

Nebulized Midazolam — full drug profile →
Intranasal Midazolam — full drug profile →

Conditions studied

Dental Sedation — all drugs for Dental Sedation →

Sponsor

Nourhan M.Aly — full company profile →

Who can join

Adults 3 to 6, any sex, with Dental Sedation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the current study is to compare the effect of intranasal versus nebulized route of administration of midazolam as moderate sedative agents in preschoolers undergoing dental treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Nourhan M.Aly trials

Trials by the same sponsor.

NCT06763419 — Internal Photobiomodulation For Management Of Temporomandibular Joint Internal Derangement · NA · recruiting
NCT06146296 — THE EFFECT OF VITAMIN C ON POST-ORTHODONTIC TREATMENT RELAPSE · Phase 2, PHASE3 · unknown
NCT05811728 — Three-dimensional Assessment of the Bone Changes Accompanying Laser-assisted Orthodontic Tooth Movement · NA · completed
NCT06352658 — Efficacy of Different Treatments for Obstructive Sleep Apnea · NA · completed
NCT05782088 — Single Versus Repeated Piezocision-assisted Orthodontic Tooth Movement · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05883150 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nourhan M.Aly
Last refreshed: 21 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05883150.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing